GlaxoSmithKline plc and Royal Dutch Shell plc: 2 income champions to protect you from Brexit risks

GlaxoSmithKline plc (LON: GSK) and Royal Dutch Shell Plc (LON: RDSB) are two companies that could be immune to Brexit risks.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There’s one concern dominating the minds of investors at the moment and that’s Brexit. Indeed, if Britain votes to leave the EU on 23 June, the country will be subject to a multi-year period of uncertainty, and it’s this uncertainty that will cause investors the most pain.

To protect against uncertainty and any adverse effects that may come as a result of Britain’s decision to leave the EU, investors could look to large international firms with well-covered dividend yields and well-positioned to succeed in any economic environment.

Defensive business 

GlaxoSmithKline (LSE: GSK) is one such company. The pharmaceuticals giant is a world leader in the production of consumer pharmaceutical products, such as over-the-counter medicines, toothpaste and painkillers. What’s more, the group has a large vaccines division as well as a stake in ViiV Healthcare, a joint venture dedicated to delivering advances in treatment and care for people living with HIV. It’s extremely unlikely that any one of these businesses will see a sudden drop-off in demand for their products in the event of a Brexit.

Moreover, this year Glaxo is on track to report its first year of earnings growth since 2011, so there’s already a significant amount of positive sentiment surrounding the group. City analysts expect the company to report earnings growth of 16% this year, followed by growth of 5% for 2017.

Management has already come out to confirm it’s on track to meet this target. In fact, the first quarter of 2016 was one of the most impressive in several years for the company. Sales increased by 11%, to £6.2bn and earnings per share, excluding exceptional items and adjusted for currency, rose 8% to 19.8p. Shares in Glaxo currently trade at a forward P/E of 15.9 and support a dividend yield of 5.7%.

Global oil company 

Royal Dutch Shell (LSE: RDSB) is another large international company that’s unlikely to be significantly affected by a leave vote. As one of the largest oil traders in Europe and one of the biggest integrated oil companies in the world, Shell is a vital part of the global economy. 

This means that the group is likely to continue to churn out returns for investors no matter what the future holds for the UK economy.

Over the next few years, Shell’s earnings should climb steadily higher as the company continues its integration of recently acquired BG Group and cuts costs further to deal with the slump in oil prices. Asset sales should bolster the enlarged group’s balance sheet while improving margins as low-return assets are sold off.

Shares in Shell currently trade at a forward P/E of 23.7 and support a dividend yield of 7.2%. Management has announced its commitment to the dividend for the foreseeable future so a payout should be secure no matter what the outcome on 23 June.

Rupert Hargreaves owns shares of GlaxoSmithKline and Royal Dutch Shell B. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Royal Dutch Shell B. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businessman hand stacking up arrow on wooden block cubes
Growth Shares

Why I think the HSBC share price could hit 2,000p by December

Jon Smith explains why the HSBC share price could be primed to rally for the rest of the year, despite…

Read more »

Elevated view over city of London skyline
Investing Articles

£15,000 invested in UK shares a decade ago is now worth…

How have UK shares performed in recent years? That depends which ones you have in mind, as our writer explains.…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

3 FTSE shares with many years of consecutive dividend growth

Paul Summers picks out a selection of FTSE shares that have offered passive income seekers consistency for quite a long…

Read more »

piggy bank, searching with binoculars
Investing Articles

Prediction: Diageo shares could soar in the next 5 years if this happens…

Diageo shares have been in the doldrums for some years now. What on earth could waken this FTSE 100 dud…

Read more »

Investing Articles

With a P/E of 5.9 is this a once-in-a-decade opportunity to buy dirt-cheap easyJet shares?

Today marks a fresh low for easyJet shares, which are falling on a disappointing set of first-half results. Harvey Jones…

Read more »

Investing Articles

Think the soaring Tesco share price is too good to be true? Read this…

The Tesco share price keeps climbing. It's up again today, following a positive set of results, but Harvey Jones says…

Read more »

Artillery rocket system aimed to the sky and soldiers at sunset.
Investing Articles

BAE Systems shares are up 274% in 46 months. And I reckon there could be more to come

Our writer’s been learning about the state of Britain’s defence forces. And he thinks it could be good news for…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

5 years ago, £5,000 bought 218 Greggs shares. How many would it buy now?

Greggs sells around 150m sausage rolls every year. But have those who bought the baker’s shares in April 2021 made…

Read more »